|

AXT-1003 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Axter Therapeutics (Beijing) Co., Ltd1

Indications

  • Non-hodgkin Lymphoma1
  • Advanced Solid Tumor1
  • Cancer1

Other1 trial

Study of AXT-1003 in Subjects With Advanced Malignant Tumors.
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.